L. Lemonnier

发表

Causes of death in French cystic fibrosis patients: The need for improvement in transplantation referral strategies!

P. Burgel, A. Munck, C. Hamard, 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients

J. Gaillard, J. Herrmann, G. Bellis, 2012, European Respiratory Journal.

Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients.

I. Pin, J. Gaillard, J. Herrmann, 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Multicenter Study of Prevalence of Nontuberculous Mycobacteria in Patients with Cystic Fibrosis in France

J. Gaillard, G. Bellis, Marie-Anne Vibet, 2009, Journal of Clinical Microbiology.

Quantifying Long-term Changes in Lung Function and Exacerbations after Initiation of Azithromycin in Cystic Fibrosis.

I. Durieu, M. Rabilloud, S. Touzet, 2020, Annals of the American Thoracic Society.

Does newborn screening influence the young cystic fibrosis cohort included in national registries?

K. De Boeck, A. Munck, V. Gulmans, 2017, European Respiratory Journal.

Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand

S. Stanojevic, P. Burgel, J. Sykes, 2022, Thorax.

Cumulative Incidence and Risk Factors for Severe COVID-19 in French People with Cystic Fibrosis

P. Reix, P. Burgel, C. Marguet, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function.

P. Reix, P. Burgel, J. Paillasseur, 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis.

S. Leroy, P. Burgel, J. Paillasseur, 2022, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis.

D. Caimmi, A. Didier, S. Leroy, 2020, American journal of respiratory and critical care medicine.

Retrospective observational study of French patients with cystic fibrosis and a Gly551Asp-CFTR mutation after 1 and 2years of treatment with ivacaftor in a real-world setting.

A. Munck, L. Mély, V. David, 2018, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry

J. Dalphin, B. Degano, P. Plésiat, 2019, PloS one.

Optimization of the French cystic fibrosis newborn screening programme by a centralized tracking process

M. Audrézet, A. Munck, D. Cheillan, 2017, Journal of medical screening.

Is there evidence for correct diagnosis in cystic fibrosis registries?

C. Castellani, F. Vermeulen, K. De Boeck, 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

High-flow cannula for frail patients with SARS-CoV-2 infection non-eligible for intensive care unit management

M. Martinot, S. Abgrall, L. Lemonnier, 2022, Infectious Diseases Now.

First Wave of COVID-19 in French Patients with Cystic Fibrosis

P. Boelle, P. Burgel, L. Guillot, 2020, Journal of clinical medicine.

CFTR‐France, a national relational patient database for sharing genetic and phenotypic data associated with rare CFTR variants

P. Fergelot, M. Claustres, A. Kitzis, 2017, Human mutation.

Temporal trends in healthcare resource use and associated costs of patients with cystic fibrosis.

I. Durieu, E. van Ganse, M. Belhassen, 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Pregnancy outcome in women with cystic fibrosis and poor pulmonary function.

I. Durieu, M. Rabilloud, S. Touzet, 2018, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Pregnancy outcome in women with cystic fibrosis‐related diabetes

I. Durieu, M. Rabilloud, S. Touzet, 2017, Acta obstetricia et gynecologica Scandinavica.

The multi-faceted nature of 15 CFTR exonic variations: Impact on their functional classification and perspectives for therapy.

P. Fergelot, M. Claustres, A. Kitzis, 2022, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Rapid Improvement After Starting Elexacaftor-tezacaftor-ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease.

P. Burgel, J. Paillasseur, I. Durieu, 2021, American journal of respiratory and critical care medicine.

Cluster and CART analyses identify large subgroups of adults with cystic fibrosis at low risk of 10-year death

S. Stanojevic, P. Burgel, J. Paillasseur, 2018, European Respiratory Journal.

Cancer incidence and prevalence in cystic fibrosis patients with and without a lung transplant in France

I. Durieu, C. Rousset-Jablonski, E. van Ganse, 2022, Frontiers in Public Health.

The French compassionate programme of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant

P. Burgel, I. Durieu, I. Sermet-Gaudelus, 2023, European Respiratory Journal.

Pregnancy outcome in women with cystic fibrosis and poor pulmonary function

I. Durieu, S. Touzet, Q. Reynaud, 2018, Revue d'épidémiologie et de santé publique.

Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study

R. Keogh, M. Macek, C. Ariti, 2021, European Respiratory Journal.

Genotypic drug resistance and cause of death in HIV-infected persons who died in 1999.

M. Lederman, H. Valdez, D. Mayers, 2001, Journal of acquired immune deficiency syndromes.

Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations.

J. Gaillard, J. Herrmann, G. Bellis, 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

WS18.1 Evolution of pregnancies in the French CF Registry: 1992–2011

I. Durieu, G. Bellis, L. Lemonnier, 2013 .

Impact of a high emergency lung transplantation programme for cystic fibrosis in France: insight from a comparison with Canada

S. Stanojevic, P. Burgel, J. Sykes, 2021, European Respiratory Journal.

Nonsense mutations accelerate lung disease and decrease survival of cystic fibrosis children.

B. Kerem, P. Reix, P. Burgel, 2023, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

French Cystic Fibrosis Registry. Annual data report 2017

G. Bellis, L. Lemonnier, C. Dehillotte, 2019 .

Does newborn screening influence the young cystic fibrosis cohort included in national registries?

K. De Boeck, A. Munck, V. Gulmans, 2017, European Respiratory Journal.

Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription

P. Reix, A. Guillaumot, I. Sermet-Gaudelus, 2023, European Respiratory Journal.